Timothy P. Walbert - 09 Jun 2025 Form 4 Insider Report for Sagimet Biosciences Inc. (SGMT)

Reporting relationship: Director
Issuer ticker: SGMT
Reported as of: 09 Jun 2025
Net transaction value: $0
SEC form: 4
Accepted by SEC: 10 Jun 2025, 17:43:22 UTC
Prior SEC filing: 02 Jun 2025
Next SEC filing: 16 Jun 2025
Source filing: View source filing
Reporting owner signature: /s/ Elizabeth Rozek, Attorney-in-Fact

Key filing fact

Timothy P. Walbert filed Form 4 for Sagimet Biosciences Inc. (SGMT) on 10 Jun 2025.

Key facts

This page summarizes Timothy P. Walbert's Form 4 filing for Sagimet Biosciences Inc. (SGMT).
1 reported transaction and 1 derivative row are listed below.
Accepted by SEC: 10 Jun 2025, 17:43.

Change

Previous filing in this sequence was filed on 02 Jun 2025.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001349376 Primary reporting owner

Walbert Timothy P

Relationship: Director
Address: SAGIMET BIOSCIENCES INC., 155 BOVET ROAD, SUITE 303, SAN MATEO
Signature: /s/ Elizabeth Rozek, Attorney-in-Fact
Signature date: 10 Jun 2025

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

SGMT transaction Derivative

Stock Option (Right to Buy)

Award

Transaction value: $0
Shares: +32,250
Change %
Price: $0.000000
Shares after: 32,250
Date: 09 Jun 2025
Ownership: Direct
Underlying class: Series A Common Stock
Underlying amount: 32,250
Exercise price: $5.33
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

The shares underlying this option shall vest and become exercisable over twelve (12) equal monthly installments following June 9, 2025, subject to the Reporting Person's continued service on each such vesting date.